228 samples
Export
<<< of 12>>>
Accession Title Sample type Organism(s) Ch Platform Series Supplementary Contact Release date
Remove filtersFilter Remove filterBW Remove filterApr 17, 2024
GSM5982714
Ribozero total RNA seq: TEV control
SRA 1 Peter Meister Apr 17, 2024
GSM5982715
Ribozero total RNA seq: dpy-26cs TEV
SRA 1 Peter Meister Apr 17, 2024
GSM5982716
Ribozero total RNA seq: kle-2cs TEV
SRA 1 Peter Meister Apr 17, 2024
GSM5982717
Ribozero total RNA seq: scc-1cs TEV
SRA 1 Peter Meister Apr 17, 2024
GSM6424685
BRC patient P1, cfDNA rep1
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424686
BRC patient P1, normal breast tissue, MNase-assisted H3 ChIP-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424687
BRC patient P1, normal breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424688
BRC patient P1, tumour breast tissue, MNase-assisted H3 ChIP-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424689
BRC patient P1, tumour breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424690
BRC patient P2, normal breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424691
BRC patient P2, tumour breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424692
BRC patient P3, cfDNA rep1
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424693
BRC patient P3, cfDNA rep2
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424694
BRC patient P3, normal breast tissue, MNase-assisted H3 ChIP-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424695
BRC patient P3, normal breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424696
BRC patient P3, tumour breast tissue, MNase-assisted H3 ChIP-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424697
BRC patient P3, tumour breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424698
BRC patient P4, normal breast tissue, MNase-assisted H3 ChIP-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424699
BRC patient P4, normal breast tissue, MNase-seq
SRA 1 Vladimir B Teif Apr 17, 2024
GSM6424700
BRC patient P4, tumour breast tissue, MNase-assisted H3 ChIP-seq
SRA 1 Vladimir B Teif Apr 17, 2024